Pathogenic variants in the GLA gene cause Fabry disease, a lysosomal storage disorder characterised by neuropathic pain, angiokeratoma, chronic kidney disease, left ventricular hypertrophy (mimicking hypertrophic cardiomyopathy (HCM)), and cerebrovascular disease. Here, GLA is linked to chronic kidney disease.